MSS FFPE DNA Reference Standard
This MSS Reference standard contains 20 biomarkers relevant to determining the status of MSI in a patient sample, including markers in the National Cancer Institutes’ standardised Bethesda panel. This matched microsatellite stable standard can be used as an additional control with our MSI standard.
MSI is used in cancer diagnostics to aid the determination of an appropriate course of treatment for a patient. qPCR and NGS workflows are used to determine MSI status in patient samples. Our reference standards are cell line-derived, for the closest representation of patient samples.